Search

everythinglearnresearchcommunity

for

Search:↓

Certain scalp tissue features can predict how well alopecia areata responds to steroid injections.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Scalp Roller therapy helped improve hair growth in patients with hard-to-treat alopecia areata.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

The document concludes that accurate diagnosis of alopecia in children relies on thorough examination and history, and while treatments exist, none can alter the course of alopecia areata, which can significantly affect a child's psychological well-being.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

Stress-related hair loss was reversed with a special medication.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

A rare scalp condition with hair loss was correctly diagnosed and treated, leading to hair regrowth.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

The document suggests more research is needed to understand skin conditions related to toothpaste and other treatments.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.